Wednesday, November 24, 2010

Early Market News: Wells Fargo (NYSE:WFC), Sprint Nextel (NYSE:S), Abbott Laboratories (NYSE:ABT)

Here is another batch of news briefings which could affect stocks on world markets in trading later today. The following stocks should see some movement: Wells Fargo (NYSE:WFC), Sprint Nextel (NYSE:S), Abbott Laboratories (NYSE:ABT). Here is a more detailed look at the news that will affect each company when trading continues. Wells Fargo (NYSE:WFC) Wells Fargo (NYSE:WFC) has offered fraud prevention tips for the holiday season. Wells Fargo (NYSE:WFC) has offered fraud prevention tips to customers this holiday season. The new approach will be the best offer from the company for the holiday shopping. The tips will help the customers in their shopping- whether online, on a mobile device, or at a store. Lisa H. Robinson, senior vice president, Head of Risk Management, Wells Fargo(NYSE:WFC) Internet Services Group said "By taking simple precautions, shoppers can reap significant benefits when it comes to fraud prevention.” Sprint Nextel (NYSE:S) Sprint Nextel (NYSE:S) has agreed on an exchange of broadband PCS spectrum with AT&T Mobility. The bandwidth of 5 MHz to 10 MHz of A or B band will be covering areas around Denver, New Orleans, Honolulu, San Francisco and elsewhere. The transaction, detailed in FCC filings, is geared towards improving each carrier’s respective wireless coverage. AT&T paid Sprint Nextel (NYSE:S) $59 million for the spectrum in parts of Colorado, Oklahoma, Florida and elsewhere in a similar exchange program in 2009. Abbott Laboratories (NYSE:ABT) It was reported that Abbott Laboratories (NYSE:ABT) has made a major advancement in renal medicine. In a phase II trial conducted in patients with diabetic kidney disease, Abbott Laboratories (NYSE:ABT)'s Atrasentan has shown promising indication that it could be a useful tool in helping to slow down progression of the illness. Results from this Phase suggest that adding atrasentan with renin-angiotensin system (RAS) inhibitors could help reduce albuminuria – the presence of protein in urine and a primary marker for diabetic nephropathy. We may see more movement when trading continues for Wells Fargo (NYSE:WFC), Sprint Nextel (NYSE:S) and Abbott Laboratories (NYSE:ABT).
tdp2664
E money daily



No comments:

Post a Comment

LinkWithin

Related Posts Plugin for WordPress, Blogger...